Published: Wed, May 30, 2018
Medicine | By Brett Sutton

Birth control pills recalled over 'unintended pregnancy' concern

Birth control pills recalled over 'unintended pregnancy' concern

Allergan, the manufacturer of Taytulla, announced Tuesday that it was issuing a nationwide recall of one lot of the pills, totaling almost 170,000 packs, after being notified of a packaging error by a physician.

The Taytulla pill pack has 24 "active" pink softgel capsules, with hormones, with "WC" printed on the outer shell in white to be taken for 24 days followed by four maroon softgel capsules, without hormones, also imprinted with WC on one side to be taken for the next four days. The Dublin, Ireland-based company reports that "specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules".

Allergan said it was made aware of the error by a physician. According to a press release, the packaging error meant that the first four days in the pack contained the maroon placebo capsules. Allergan provided a chart, below, outlining the pill packs in question.

Allergan issued a voluntary recall Tuesday of a brand of birth control after some of the pills were put out of order. Reversing the order may not be evident to new or previous users, which can further increase the chance of taking the capsules out of sequence. The total lot of recalled packs originally had been distributed to doctors across the country who can offer them to patients as samples. The brown placebo pills should be the last four of the pack. May 2019. The drug maker urged patients to consult their physicians if they think they are affected by the recall.

STAT points out this is just the latest negative news for Allergan so far this year.

Like this: